• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home » Bharat Biotech » Page 4

Bharat Biotech

  • Covid Update

    Serum Institute, Bharat Biotech asked to slash vaccine prices

    Several states had objected to the higher prices being charged from them and private hospitals by the vaccine makers

  • Covid Update

    Covaxin: Twitterati spill anger over Bharat Biotech’s Covaxin pricing

    Majority of the Indian twitter users have expressed their anger on social media over variation in the costs of vaccine set for people.

  • Covid Update

    Covaxin price in India: Rs 600/dose to state governments, Rs 1,200/dose to private hospitals

    "We would like to state that more than 50% of our capacities have been reserved for central government  supplies," said Krishna M Ella, Bharat Biotec

  • Covid Update

    Pricing the COVID jab: Covishield cheaper than earlier indications by the company

    While the Indian vaccine is cheaper than the foreign makes, it is up to the state governments to dig into their coffers and offer the vaccine for free

  • Covid Update

    Covaxin neutralises double mutant strain: ICMR

    Bharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe

  • Covid Update

    COVID-19: Government’s expert panel allows clinical trials for third dose of Covaxin

    Bharat Biotech presented amendments to the subject expert committee of DCGI in the approved Phase 2 clinical trial protocol for administration of boos

  • Opinion

    Money9 Edit | Vaccine makers should get financial assistance

    India is at an advantageous position as two companies are producing the vaccine and the government should extend all help to increase production

  • Covid Update

    Bharat Biotech’s Covaxin out of ‘clinical trial’ mode

    Covaxin has now been granted the restricted emergency use authorisation

  • Covid Update

    COVID-19 vaccine: Delhi High Court asks SII, Bharat Biotech to disclose capacity

    The court said the two companies which have developed the vaccines (Covishield and Covaxin) have more capacity but it seems that it is not being explo

  • Exclusive

    COVID-19 vaccine: Biological E, Dr Reddy’s and Bharat Bio launch Phase-3 trials

    After the Phase 3 data is submitted, India can expect an increase in the current rate of the immunisation programme.

  • ←
  • 1
  • 2
  • 3
  • 4

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • इंडिगो की 180 से अधिक उड़ानें रद्द
  • भारत-रूस समिट में बड़े फैसलों की तैयारी, इकोनॉमिक पार्टनरशिप पर बड़ा फोकस
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close